6Brembill Perrot B,Houriez P,Beurrier D,et al.The differential diagnosis of supraventricular tachycardia using clinical and electrocardiographic features[J].Ann Acad Med Singapore,2000,29(5):653-657. 被引量：1
2Hohnloser SH, Kuck HH, Lihenthal J, et al. Rhythm or rate control in atrial fibrillation: Pharmacological Intervention in Atrial Fibrillation (PIAF): a randomized trial. Lancet, 2000,356:1789-1794. 被引量：1
3The AFFIRM Investigators. A comparison of rate control and rhythm control in patients with atrial fibrillation. N Engl J Med, 2002, 347:1825-1833. 被引量：1
4Van Gelder IC, Hagens VE, Bosker HA, et al. A comparison of rate control and rhythm control in patients with recurrent persistent atrial fibrillation. N Engl J Med, 2002,247:1834-1840. 被引量：1
5Carlsson J, Miketic S, Windeler J, et al. Randomized trial of ratecontrol versus rhythm-control in persistent atrial fibrillation: the Strategies of Treatment of Atrial Fibrillation (STAF) study. J Am Coll Cardiol, 2003,41 : 1690-1696. 被引量：1
6Weerasooriya R, Davis M, Powell A, et al. The Australian Intervention Randomized Control of Rate in Atrial Fibrillation Trial (AIRCRAFT). J Am Coll Cardiol, 2003,41:1697-1701. 被引量：1
7Pappone C, Augello G, Vicedomini G, et al. Ablation versus medical therapy for atrial fibrillation: who benefit the most? Pacing Clin Electrophysiol, 2003,26(4 pt Ⅱ ):986. 被引量：1
8The Cardiac Arrhythmia Suppression Trial (CAST) Investigators.Preliminary report: effect of encainide and flecainide on mortality and a randomized trial of arrhythmia suppression after myocardial infarction. N Engl J Med, 1989,321:406-412. 被引量：1
9Zipes DP, Wellens HJJ. What have we learned about cardiac arrhythmias? Circulation, 2000,102(20 Suppl 4) :Ⅳ52-57. 被引量：1
10Sager PT. New advances in class Ⅲ antiarrhythmic drug therapy. Curr Opin Cardiol, 2000,15:41-53. 被引量：1
